Standard Biotools (LAB) Research & Development (2010 - 2026)
Standard Biotools (LAB) posted quarterly Research & Development of $2.1 million for Q1 2026, down 61.08% year-over-year from $5.4 million in Q1 2025, and down 73.43% quarter-over-quarter from $8.0 million in Q4 2025.
Standard Biotools (LAB) Research & Development (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Research & Development for 17 consecutive years, with $2.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Research & Development fell 61.08% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $22.7 million (down 15.0% YoY), while the FY2025 annual figure was $26.0 million, down 9.86% from the prior year.
- Research & Development retreated to $2.1 million in Q1 2026 per LAB's latest filing, from $8.0 million in the prior quarter.
- Across five years, Research & Development topped out at $16.0 million in Q1 2024 and bottomed at $2.1 million in Q1 2026.
- Historically, Research & Development has averaged $7.6 million across 5 years, with a median of $6.9 million in 2024.
- Annual changes were most pronounced in 2022 — Research & Development plunged 71.14% — and 2024, when it soared 148.56%.
- Standard Biotools' Research & Development stood at $7.4 million in 2022, then dropped by 6.95% to $6.9 million in 2023, then advanced by 1.9% to $7.0 million in 2024, then gained by 13.2% to $8.0 million in 2025, then slumped by 73.43% to $2.1 million in 2026.
- Business Quant data shows LAB's Research & Development at $2.1 million in Q1 2026, $8.0 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.20 Bn | 193.60 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.66 Bn | 124.19 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.37 Bn | 32.42 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 33.89 Bn | 31.78 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -562.58 Mn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn | 28.60 Mn |
| 10 | Standard Biotools | 253.06 Mn | -223.66 Mn | 10.54 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.98 Mn |
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 7.97 Mn |
| Sep 30, 2025 | 6.36 Mn |
| Jun 30, 2025 | 6.22 Mn |
| Mar 31, 2025 | 5.44 Mn |
| Dec 31, 2024 | 7.04 Mn |
| Sep 30, 2024 | 6.94 Mn |
| Jun 30, 2024 | 7.24 Mn |
| Mar 31, 2024 | 15.98 Mn |
| Dec 31, 2023 | 6.91 Mn |
| Sep 30, 2023 | 6.37 Mn |
| Jun 30, 2023 | 6.18 Mn |
| Mar 31, 2023 | 6.43 Mn |
| Dec 31, 2022 | 7.43 Mn |
| Sep 30, 2022 | 8.49 Mn |
| Jun 30, 2022 | 12.61 Mn |
| Mar 31, 2022 | 8.87 Mn |
| Sep 30, 2021 | 29.40 Mn |
| Jun 30, 2021 | 20.19 Mn |